‘Because there is more to do’ Report
Listening to people, patients, carers, patient groups and healthcare professionals
The 'Because there is more to do' report presents the results of this public listening initiative of Bristol Myers Squibb.
In late 2020, we opened two surveys to ask people for their feedback on health issues, and how they see the role of pharma companies in supporting patients beyond the provision of medicines. A public survey invited everyone across eight European countries to participate. Discover the findings in the ‘Because there is more to do’ report.
